Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
作者： Satoru Kuriyama , Haruo Tomonari , Aya Abe , Toshiyuki Imasawa , Tatsuo Hosoya
DOI: 10.1159/000045855
关键词: Angiotensin receptor 、 Proteinuria 、 Diabetic nephropathy 、 Angiotensin-converting enzyme 、 Internal medicine 、 Combination therapy 、 Angiotensin II receptor antagonist 、 Endocrinology 、 Angiotensin II receptor type 1 、 Medicine
摘要:
karger.com 
sci-hub.se 参考文章(10)
Ziai F, Troy Jl, Rennke Hg, Brenner Bm, Provoost Ap, Ots M, Mackenzie Hs, The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney International. ,vol. 57, ,(1996)
Akiko Imamura, Harald S. Mackenzie, Eric R. Lacy, Florence N. Hutchison, Wayne R. Fitzgibbon, David W. Ploth, Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. Kidney International. ,vol. 47, pp. 1394- 1402 ,(1995) , 10.1038/KI.1995.196
Masahiro Kohzuki, Minoru Yasujima, Masayuki Kanazawa, Kazunori Yoshida, Liu Ping Fu, Katsuya Obara, Takao Saito, Keishi Abe, None, Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. Journal of Hypertension. ,vol. 13, pp. 97- 103 ,(1995) , 10.1097/00004872-199501000-00015
Yoshihiko Kakinuma, Tetsuya Kawamura, Teresa Bills, Toshimasa Yoshioka, Iekuni Ichikawa, Agnes Fogo, Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure Kidney International. ,vol. 42, pp. 46- 55 ,(1992) , 10.1038/KI.1992.259
Domenico Russo, Antonio Pisani, Mario M. Balletta, Luca De Nicola, Francesco A. Savino, Michele Andreucci, Roberto Minutolo, Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy American Journal of Kidney Diseases. ,vol. 33, pp. 851- 856 ,(1999) , 10.1016/S0272-6386(99)70416-6
John C. Peterson, Blood Pressure Control, Proteinuria, and the Progression of Renal Disease Annals of Internal Medicine. ,vol. 123, pp. 754- 762 ,(1995) , 10.7326/0003-4819-123-10-199511150-00003
J L Troy, H G Rennke, B M Brenner, M Ots, H S Mackenzie, Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. Journal of The American Society of Nephrology. ,vol. 9, pp. 224- 230 ,(1998) , 10.1681/ASN.V92224
P F Mento, B M Wilkes, Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension. ,vol. 9, pp. 42- 48 ,(1987) , 10.1161/01.HYP.9.6_PT_2.III42
H Urata, K D Boehm, A Philip, A Kinoshita, J Gabrovsek, F M Bumpus, A Husain, Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. Journal of Clinical Investigation. ,vol. 91, pp. 1269- 1281 ,(1993) , 10.1172/JCI116325
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The New England Journal of Medicine. ,vol. 330, pp. 1456- 1462 ,(1993) , 10.1056/NEJM199403313301314